Supernus Pharmaceuticals
SUPN
$30.07
Share price
2.59%
Change (1 day)
-18.42%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Cash on Hand
Cash on Hand as of December 2023 : $0.25 B
According to Supernus Pharmaceuticals
's latest financial reports the company has $0.25 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.25 B | -44.75% |
| 2022-12-31 | $0.46 B | 35.81% |
| 2021-12-31 | $0.33 B | -19.61% |
| 2020-12-31 | $0.42 B | 21.74% |
| 2019-12-31 | $0.34 B | -2.51% |
| 2018-12-31 | $0.35 B | 154.23% |
| 2017-12-31 | $0.14 B | 55.39% |
| 2016-12-31 | $90.12 M | 44.91% |
| 2015-12-31 | $62.19 M | -16.34% |
| 2014-12-31 | $74.33 M | -9.56% |
| 2013-12-31 | $82.19 M | -7.14% |
| 2012-12-31 | $88.5 M | 82.33% |
| 2011-12-31 | $48.54 M | 48.43% |
| 2010-12-31 | $32.7 M | -50.84% |
| 2009-12-31 | $66.52 M | 10.18% |
| 2008-12-31 | $60.37 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 8,895.43% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 2,755.92% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 1,048.69% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 3,694.03% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 United Therapeutics UTHR | $2.99 B | 1,074.74% | 🇺🇸 USA |